ALCON INC
No SEC Form 4 filings for $ALC in the last 30 days.
See all $ALC insider activity →Pershing Square’s Q2 update says Bill Ackman’s Pershing Square USA (PSUS) raised a $5 billion IPO and has deployed over 95% of PSUS capital across 14 investments, including new positions in Visa, Mastercard, Intercontinental Exchange, Netflix, Alcon and S&P Global. The article lists Q2 2026 holdings and notes Ackman’s long-term return goal above 20% gross annually.
Alcon reported Q2 2026 results showing higher sales and revenue but lower net income, according to the company. It kept 2026 net sales growth guidance and noted a collaboration with RxSight. Analysts cited a CHF76.62 fair value versus a CHF59.48 close and highlighted product launches and recent acquisitions, while valuation metrics showed a 54.9x P/E versus industry averages.
Simply Wall St discusses Alcon’s Q2 2026 earnings, saying sales and revenue rose but net income fell, while 2026 net sales growth guidance was maintained. It also cites a RxSight collaboration and notes Alcon’s shares returned 17.97% over 90 days but -13.93% over one year. A “fair value” of CHF76.62 vs CHF59.48 is referenced.
Over the past 7 days, alphai's AI scored 18 news stories mentioning ALC (ALCON INC). Coverage has skewed bullish: 12 bullish, 5 neutral, and 1 bearish.
Recent ALC coverage spans financial news, technology and earnings.
Alcon’s inclusion as a new holding may support incremental investor interest but does not constitute new Alcon news.
Mixed earnings quality and valuation premium suggest traders may fade the rebound unless margins and integration execution improve.
The article is primarily valuation and narrative framing, not a new operational or regulatory catalyst for Alcon.
ALC is the most fundamentals-supported name in the list due to the included Q1 and 2026 outlook numbers.
New disclosed entry may support the stock if investors track Pershing Square, but there is no Alcon trial, approval, or guidance update here.
alphai scores every news story that mentions ALC with an AI model for sentiment and relevance, and aggregates insider trades from ALCON INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Pershing Square’s Q2 update says Bill Ackman’s Pershing Square USA (PSUS) raised a $5 billion IPO and has deployed over 95% of PSUS capital across 14 investments, including new positions in Visa, Mastercard, Intercontinental Exchange, Netflix, Alcon and S&P Global. The article lists Q2 2026 holdings and notes Ackman’s long-term return goal above 20% gross annually.
6 min readAlcon reported Q2 2026 results showing higher sales and revenue but lower net income, according to the company. It kept 2026 net sales growth guidance and noted a collaboration with RxSight. Analysts cited a CHF76.62 fair value versus a CHF59.48 close and highlighted product launches and recent acquisitions, while valuation metrics showed a 54.9x P/E versus industry averages.
5 min readSimply Wall St discusses Alcon’s Q2 2026 earnings, saying sales and revenue rose but net income fell, while 2026 net sales growth guidance was maintained. It also cites a RxSight collaboration and notes Alcon’s shares returned 17.97% over 90 days but -13.93% over one year. A “fair value” of CHF76.62 vs CHF59.48 is referenced.
6 min readPershing Square Capital Management, led by Bill Ackman, added six new stocks to its portfolio: Netflix, Visa, Mastercard, S&P Global, Intercontinental Exchange, and Alcon, aiming for durable earnings growth and free cash flow. The article cites expected 20% EPS growth over 3-5 years and valuation around 19x earnings. It also notes Netflix Q2 revenue up 13.4% to $12.6B and Alcon fiscal Q1 sales $2.7B.
7 min readBill Ackman’s Pershing Square added six new holdings between end-March and end-June 2026: Netflix, Visa, Mastercard, S&P Global, Intercontinental Exchange, and Alcon, while exiting Universal Music Group and Alphabet and selling Hertz in July. Reported YTD returns: Netflix -16.5%, Visa 4.2%, Mastercard 0.67%, S&P Global -15%, ICE -4.15%, Alcon -6.7%. Pershing Square NAV YTD (Aug 11, 2026) was -4.3% vs S&P 500 +13.7%.
6 min readAlcon terminated its PowerVision intraocular lens program after clinical data showed unpredictable postoperative distance-vision outcomes, according to the company. The decision led to a $402 million write-off in Q2. Alcon, which bought PowerVision in 2019 for $285 million, said it will continue investing in next-generation IOLs and in July began a non-exclusive collaboration with RxSight.
3 min readAlcon Inc. (NYSE:ALC) and RxSight, Inc. (NASDAQ:RXST) announced a non-exclusive collaboration to co-develop post-operative adjustable pseudophakic intraocular lenses using RxSight’s light-adjustable technology. Alcon also opened a second training center in India with Aravind. Q1 2026: Alcon net sales $2.7B (+10% YoY), core EPS $0.85, FCF $279M. RxSight revenue $30.9M (-18.5% YoY), net loss $15.9M, gross margin 76.1%.
6 min readBill Ackman disclosed six new holdings, including buying Netflix, Visa, Mastercard, Alcon, Intercontinental Exchange, and S&P Global from Q2 onward, across Pershing Square USA and other funds. He said he expects strong earnings growth. Pershing Square USA was up 1.66% on the day and down 3.5% YTD through July.
5 min readPershing Square Holdings’ interim report says Bill Ackman’s funds initiated new positions in Netflix (NFLX) and five other stocks in Q2 after Ackman raised about $5 billion via Pershing Square USA and Pershing Square Inc. Netflix was bought after a 50% drop post June 2025 highs, with the fund citing valuation and AI-related advantages. Other buys: Visa, Mastercard, S&P Global, Intercontinental Exchange, and Alcon.
6 min readBill Ackman disclosed new stakes in six companies for his investment funds, including Netflix (NFLX), Visa (V), Mastercard (MA), Alcon (ALC), Intercontinental Exchange (ICE), and S&P Global (SPGI). He said shares were bought starting in Q2 for Pershing Square USA, listed in April, and expects strong earnings growth. The changes may appear in upcoming 13-F filings.
6 min read
